Some of 2010’s most troubled companies will be on investors’ radars this week, with a strategic update from Telstra and results from Sigma Pharmaceuticals and Nufarm.
Telstra will again be in the spotlight, with the company set to offer a detailed explanation of its future business strategy.
Loading...
Anthony Macdonald is a Chanticleer columnist. He is a former Street Talk co-editor and has 10 years' experience as a business journalist and worked at PwC, auditing and advising financial services companies. Connect with Anthony on Twitter. Email Anthony at a.macdonald@afr.com
